Abstract
SummarySuitable test systems are described for demonstrating a fibrinolysis enhancing effect of ellagic acid (in vitro), which resembles that of other surface-active agents (e. g., kaolin) in its dependence upon Hageman factor activation, but differs in certain relatively minor particulars. These differences may be explained, at least in part, by demonstrated inhibitory actions of ellagic acid, also shown in suitable test systems. Balances between activations and inhibitions may very well depend on particular types of surface. In the complex interplay between plasma factor and surfaces resides, in all probability, the balances between clotting (or thrombosis) and fibrinolysis (or thrombolysis), upon which depend the integrity and functions of the blood-flow systems, and the understanding of bleeding and thrombosis problems.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
